Malaria remains a major public health challenge, with over 200 million cases and hundreds of thousands of deaths annually.
Progress in reducing incidence has plateaued. The Plasmodium parasite has a complex lifecycle including a liver stage and blood stages.
Traditional 2D cell cultures and animal models have limitations in capturing human physiology, especially for liver-stage infection and dormant hypnozoites. Advanced in vitro systems—including organoids, microphysiological platforms, and induced pluripotent stem cell (iPSC)-derived tissues—are being developed to overcome these limitations, enabling more accurate study of parasite biology and drug testing.
Key Developments
Liver Stage Models
3D systems and co-cultures extend hepatocyte viability and support full parasite development, including hypnozoite formation, which is essential for studying relapsing malaria.
Microphysiological Systems (Organ-on-a-Chip)
Microfluidic devices simulate liver lobule microarchitecture, maintain cell function long-term, and model tissue-specific environments like the blood-brain barrier.
Stem Cell-Derived Systems
iPSCs can differentiate into hepatocytes or erythrocytes, providing scalable, genetically modifiable human cell sources for personalized medicine.
High-Throughput Screening
Imaging-based assays and biosensor-integrated organ-on-a-chip platforms enable rapid evaluation of thousands of compounds.
Challenges and Gaps
- Technical complexity and high cost limit accessibility and standardization.
- Modeling the full lifecycle in a single integrated system remains difficult.
- Long-term culture of P. vivax hypnozoites and maintenance of hepatocyte functionality are major bottlenecks.
Outlook
The future of malaria research involves combining organoid technology, microfluidics, and genomics to create integrated models that better replicate human physiology, reduce reliance on animal models, and accelerate drug discovery.